Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
roche
6
×
life sciences
national blog main
national top stories
biotech
boston blog main
boston top stories
fda
national
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
companion diagnostic
deals
detroit blog main
detroit top stories
drug pricing
europe top stories
foundation medicine
genentech
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
What
medicine
6
×
roche
drug
fda
new
approved
big
billion
deal
oral
recently
second
swiss
therapy
acquire
agreed
announced
antiviral
approval
atea
atrophy
betting
bio
biopharma
bosley's
bosley’s
bridge
broad
bucks
cancer
cas
ceo
confidence
coronavirus
crime
crispr
cure
currently
daily
deeper
Language
unset
Current search:
roche
×
medicine
×
@bgr.com
3 years ago
This groundbreaking new coronavirus cure is unlike any other drug we’ve seen so far
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine